These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Use of antilymphocyte globulin after cadaveric renal transplantation. Doak PB; Dalton NT; Meredith J; Montgomerie JZ; North JD Br Med J; 1969 Nov; 4(5682):522-5. PubMed ID: 4901345 [TBL] [Abstract][Full Text] [Related]
7. Changes in serum immunoglobulin and complement levels following renal homotransplantation. Levine PH; Merrill DA; Kohler PF; Claman HN Transplantation; 1970 Aug; 10(2):141-54. PubMed ID: 4915554 [No Abstract] [Full Text] [Related]
8. Combined immunosuppression for canine renal allograft prolongation: antilymphocyte serum plus prednisolone or azathioprine. Weil R; Simmons RL Ann Surg; 1968 Feb; 167(2):239-45. PubMed ID: 4866845 [No Abstract] [Full Text] [Related]
9. Clinical use of antilymphoblast serum. Najarian JS; Merkel FK; Moore GE; Good RA; Aust JC Transplant Proc; 1969 Mar; 1(1):460-2. PubMed ID: 5002662 [No Abstract] [Full Text] [Related]
10. [Renal homotransplantation in men. Results achieved in 37 patients 26 of whom had received antilymphocyte globulins]. Küss R; Legrain M; Le Gall JR; Guédon J; Poisson J J Urol Nephrol (Paris); 1969 Sep; 75(9):594-600. PubMed ID: 4103960 [No Abstract] [Full Text] [Related]
11. Immunosuppressive drugs used in clinical renal transplantation. Chatterjee SN Urology; 1977 Jun; 9(6 Suppl):52-60. PubMed ID: 70101 [No Abstract] [Full Text] [Related]
12. Renal homotransplantation in infants and children with the hemolytic-uremic syndrome. Cerilli GJ; Nelsen C; Dorfmann L Surgery; 1972 Jan; 71(1):66-71. PubMed ID: 4550237 [No Abstract] [Full Text] [Related]
13. A heart transplantation. 8. Immunological and haematological aspects. Biggs JC Med J Aust; 1969 Mar; 1(13):681-3. PubMed ID: 4181420 [No Abstract] [Full Text] [Related]
14. Initial treatment of renal allografts with large intrarenal doses of immunosuppressive drugs. Kountz SL; Cohn R Lancet; 1969 Feb; 1(7590):338-40. PubMed ID: 4179352 [No Abstract] [Full Text] [Related]
15. Long-term survival after renal transplantation in humans: (with special reference to histocompatibility matching, thymectomy, homograft glomerulonephritis, heterologous ALG , AND RECIPIENT MALIGNANCY). Starzl TE; Porter KA; Andres G; Halgrimson CG; Hurwitz R; Giles G; Terasaki PI; Penn I; Schroter GT; Lilly J; Starkie SJ; Putnam CW Ann Surg; 1970 Sep; 172(3):437-72. PubMed ID: 4918003 [No Abstract] [Full Text] [Related]
16. The clinical use of antilymphocyte globulin in renal homotransplantation. Starzl TE; Marchioro TL; Hutchinson DE; Porter KA; Cerilli GJ; Brettschneider L Transplantation; 1967 Jul; 5(4):Suppl:1100-5. PubMed ID: 4167452 [TBL] [Abstract][Full Text] [Related]
17. The use of low doses of cyclosporine, azathioprine, and prednisone in renal transplantation. First MR; Alexander JW; Wadhwa N; Penn I; Munda R; Fidler JP; Weiskittel P Transplant Proc; 1986 Apr; 18(2 Suppl 1):132-5. PubMed ID: 3515680 [No Abstract] [Full Text] [Related]
18. Functional characterization of blocking antibody after human renal transplantation. Miller J; Lifton J; Rood F; Kyriakides G; Gajl-Peczalska KY; Yunis EJ; Hattler BG Surgery; 1974 Jul; 76(1):129-41. PubMed ID: 4135311 [No Abstract] [Full Text] [Related]